We are live on ! Find out more
SC

Samlyn Capital Portfolio holdings

AUM $5.86B
1-Year Est. Return 36.3%
This Fund
S&P 500
This Quarter Est. Return
+6.72%
1 Year Est. Return
+36.3%
3 Year Est. Return
+115.4%
5 Year Est. Return
+175.71%
10 Year Est. Return
+881.8%
AUM
$6.62B
AUM Growth
+$14.4M
Cap. Flow
-$183M
Cap. Flow %
-2.76%
Top 10 Hldgs %
37.78%
Holding
122
New
31
Increased
24
Reduced
36
Closed
29

Sector Composition

1 Financials 27.49%
2 Consumer Discretionary 25.07%
3 Technology 13.53%
4 Healthcare 11.08%
5 Industrials 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLN icon
76
Haleon
HLN
$44.3B
$22.4M 0.34%
+2,350,130
New +$23M
IDYA icon
77
IDEAYA Biosciences
IDYA
$3.48B
$20.4M 0.31%
792,399
-24,908
-3% -$705K
RPRX icon
78
Royalty Pharma
RPRX
$25.9B
$18.5M 0.28%
+726,018
New +$19.3M
SLNO
79
DELISTED
Soleno Therapeutics
SLNO
$17M 0.26%
378,103
-133,709
-26% -$6.93M
DFS
80
DELISTED
Discover Financial Services
DFS
$16.9M 0.26%
97,494
-682,058
-87% -$112M
CELC icon
81
Celcuity
CELC
$4.31B
$16.4M 0.25%
1,251,593
-39,342
-3% -$555K
CE icon
82
Celanese
CE
$5B
$14.7M 0.22%
+212,070
New +$20.4M
CIFR icon
83
Cipher Digital
CIFR
$7.11B
$11.5M 0.17%
+2,485,387
New +$14.1M
AUB icon
84
Atlantic Union Bankshares
AUB
$6.07B
$11.2M 0.17%
+295,293
New +$11.7M
INSM icon
85
Insmed
INSM
$23.5B
$11M 0.17%
159,064
-52,434
-25% -$3.78M
CCCC icon
86
C4 Therapeutics
CCCC
$406M
$10.9M 0.16%
+3,019,458
New +$15M
MRX
87
Marex Group Limited Ordinary Shares
MRX
$4.32B
$10.1M 0.15%
324,958
-35,131
-10% -$983K
PCTTW
88
PureCycle Technologies Inc Warrant
PCTTW
$11.4M
$9.81M 0.15%
2,857,142
NRIX icon
89
Nurix Therapeutics
NRIX
$2.39B
$9.72M 0.15%
515,840
-52,424
-9% -$1.2M
NKTR icon
90
Nektar Therapeutics
NKTR
$2.29B
$8.99M 0.14%
644,470
+31,140
+5% +$549K
VTMX icon
91
Vesta Real Estate
VTMX
$3.22B
$1.91M 0.03%
74,520
+60,823
+444% +$1.56M
VOO icon
92
Vanguard S&P 500 ETF
VOO
$974B
$220K ﹤0.01%
+409
New +$222K
AMD icon
93
Advanced Micro Devices
AMD
$807B
-524,697
Closed -$86.1M
BFAM icon
94
Bright Horizons
BFAM
$4.02B
-327,278
Closed -$45.9M
BLDR icon
95
Builders FirstSource
BLDR
$7.96B
-216,641
Closed -$42M
BUD icon
96
AB InBev
BUD
$155B
-1,027,591
Closed -$68.1M
CMA
97
DELISTED
Comerica
CMA
-1,196,908
Closed -$71.7M
CPRI icon
98
Capri Holdings
CPRI
$1.89B
-1,187,836
Closed -$50.4M
CRC icon
99
California Resources
CRC
$4.68B
-179,611
Closed -$9.42M
DNUT icon
100
Krispy Kreme
DNUT
$569M
-1,757,948
Closed -$18.9M

Similar funds

Samlyn Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Samlyn Capital held 122 positions worth $6.62B, up 0.22% from $6.61B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Samlyn Capital's Q4 2024 filing shows 31 new, 24 increased, 36 reduced and 29 closed positions. Its largest new stake was Arthur J. Gallagher & Co: 399,477 shares worth $113M. The largest sale was Take-Two Interactive, an estimated $130M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Samlyn Capital's largest Q4 2024 buy was Arthur J. Gallagher & Co: 399,477 shares worth $113M.
  • Samlyn Capital added most to Capital One in Q4 2024, an estimated $155M increase.
  • Samlyn Capital's biggest Q4 2024 reduction was Spotify, cutting an estimated $130M.
  • Samlyn Capital fully exited Take-Two Interactive in Q4 2024, selling an estimated $130M.
  • Samlyn Capital's ten largest holdings make up 38% of its $6.62B portfolio in Q4 2024.
  • Samlyn Capital opened 31 new positions and closed 29 in Q4 2024.
  • Samlyn Capital's portfolio value rose 0.22% quarter-over-quarter to $6.62B.

Based on Samlyn Capital's 13F filing for Q4 2024, filed 14 Feb 2025.